CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Open-market sale Chief Financial Officer sold 238 shares at $14.05 ($3,344)
- 4 Planned sale Chief Scientific Officer sold 10,000 shares at $14.82 ($148,200)
- 4 Planned sale CEO and Chairman sold 89,265 shares at an average $14.73 ($1,315,180)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Agreement ended
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Shareholder vote results
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4/A Open-market sale Chief Financial Officer sold 1,929 shares at $8.89 ($17,149)
- 4 Open-market sale Chief Financial Officer sold 1,929 shares at $8.89 ($17,149)
- SCHEDULE 13G Stake Statement of Beneficial Ownership
Page 10 of 42 · 836 filings